The DOI matches its Crossref record; 344 of the 344 references it cites were found in a registry or an index.
Malignant Pleural Mesothelioma
Open accessAbstract
Malignant pleural mesothelioma (MPM) is a deadly disease that occurs in 2,000 to 3,000 people each year in the United States. Although MPM is an extremely difficult disease to treat, with the median overall survival ranging between 9 and 17 months regardless of stage, there has been significant progress over the last few years that has reshaped the clinical landscape. This article will provide a comprehensive discussion of the latest developments in the treatment of MPM. We will provide an update of the major clinical trials that impact mesothelioma treatment in the resectable and unresectable settings, discuss the impact of novel therapeutics, and provide perspective on where the clinical research in mesothelioma is moving. In addition, there are controversial issues, such as the role of extrapleural pneumonectomy, adjuvant radiotherapy, and use of intensity-modulated radiotherapy versus hemithoracic therapy that will also be addressed in this manuscript.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Gomer, C. J. (1988) · Cited by 4,174
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Vogelzang, N. J., Rusthoven, J. J., Symanowski, J., Denham, C., Kaukel, E., Ruffie, P., Gatzemeier, U., Boyer, M., Emri, S., Manegold, C., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.136 · Cited by 3,060
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
Devesa, S. S., Blot, W. J., & Fraumeni, J. F. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19981115)83:10<2099::aid-cncr8>3.0.co;2-3 · Cited by 2,101
Rusch, V. W., Asamura, H., Watanabe, H., Giroux, D. J., Rami-Porta, R., & Goldstraw, P. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a0d82e · Cited by 1,209
Tissue repair and stem cell renewal in carcinogenesis
Beachy, P. A., Karhadkar, S. S., & Berman, D. M. (2004) · Nature · doi:10.1038/nature03100 · Cited by 1,208
Sugarbaker, D. J., Flores, R. M., Jaklitsch, M. T., Richards, W. G., Strauss, G. M., Corson, J. M., DeCamp, M. M., Swanson, S. J., Bueno, R., Lukanich, J. M., et al. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70469-1 · Cited by 985
The European mesothelioma epidemic
Peto, J., Decarli, A., Vecchia, C. L., Levi, F., & Negri, E. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690105 · Cited by 891
Advances in Malignant Mesothelioma
Robinson, B. W. S., & Lake, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050152 · Cited by 889
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
Travis, L. B., Fosså, S. D., Schonfeld, S. J., McMaster, M. L., Lynch, C. F., Storm, H., Hall, P., Holowaty, E., Andersen, A., Pukkala, E., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji278 · Cited by 823
Modified RECIST criteria for assessment of response in malignant pleural mesothelioma
Byrne, M. J., & Nowak, A. K. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh059 · Cited by 645
Scherpereel, A., Astoul, P., Baas, P., Berghmans, T., Clayson, H., de Vuyst, P., Dienemann, H., Galateau-Salle, F., Hennequin, C., Hillerdal, G., et al. (2010) · European Respiratory Journal · doi:10.1183/09031936.00063109 · Cited by 638
Flores, R. M., Pass, H. I., Seshan, V. E., Dycoco, J., Zakowski, M., Carbone, M., Bains, M. S., & Rusch, V. W. (2008) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2007.10.054 · Cited by 617
van Meerbeeck, J. P., Gaafar, R., Manegold, C., Van Klaveren, R. J., Van Marck, E. A., Vincent, M., Legrand, C., Bottomley, A., Debruyne, C., & Giaccone, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.20005.14.589 · Cited by 617
Curran, D., Sahmoud, T., Therasse, P., van Meerbeeck, J., Postmus, P. E., & Giaccone, G. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.145 · Cited by 543
CT in differential diagnosis of diffuse pleural disease.
Leung, A. N., Müller, N. L., & Miller, R. R. (1990) · American Journal of Roentgenology · doi:10.2214/ajr.154.3.2106209 · Cited by 535
Mesothelin-family proteins and diagnosis of mesothelioma
Robinson, B. W., Creaney, J., Lake, R., Nowak, A., Musk, A. W., de Klerk, N., Winzell, P., Hellstrom, K. E., & Hellstrom, I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14794-0 · Cited by 534
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
Wong, I. H. N., Lo, Y. M. D., Zhang, J., Liew, C.-T., Ng, M. H. L., Wong, N., Lai, P. B. S., Lau, W. Y., Hjelm, N. M., & Johnson, P. J. (1999) · PubMed · Cited by 517
Herndon, J. E., Green, M. R., Chahinian, A. P., Corson, J. M., Suzuki, Y., & Vogelzang, N. J. (1998) · Chest · doi:10.1378/chest.113.3.723 · Cited by 504
Mossman, B. T., & Gee, J. B. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202604 · Cited by 497
Rusch, V. W., Rosenzweig, K., Venkatraman, E., Leon, L., Raben, A., Harrison, L., Bains, M. S., Downey, R. J., & Ginsberg, R. J. (2001) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2001.116560 · Cited by 493
Krug, L. M., Pass, H. I., Rusch, V. W., Kindler, H. L., Sugarbaker, D. J., Rosenzweig, K. E., Flores, R., Friedberg, J. S., Pisters, K., Monberg, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.3943 · Cited by 467
Self-citationBoutin, C., Rey, F., & Viallat, J.-R. (1995) · Chest · doi:10.1378/chest.108.3.754 · Cited by 464
Hassan, R., Bera, T., & Pastan, I. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0801 · Cited by 441
Simian virus 40-like DNA sequences in human pleural mesothelioma.
Carbone, M., Pass, H. I., Rizzo, P., Marinetti, M. R., Muzio, M. D., Mew, D., Levine, A. S., & Procopio, A. D. (1994) · PubMed · Cited by 397
Sugarbaker, D. J., Jaklitsch, M. T., Bueno, R., Richards, W. G., Lukanich, J. M., Mentzer, S. J., Colson, Y. L., Linden, P. A., Chang, M. Y., Capalbo, L., et al. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.02.021 · Cited by 395
The pathogenesis of mesothelioma
Carbone, M., Kratzke, R. A., & Testa, J. R. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.30227 · Cited by 392
Hassan, R., Bullock, S., Premkumar, A., Kreitman, R. J., Kindler, H., Willingham, M. C., & Pastan, I. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0869 · Cited by 379
Self-citationBianchi, A. B., Mitsunaga, S. I., Cheng, J. Q., Klein, W. M., Jhanwar, S. C., Seizinger, B., Kley, N., Klein-Szanto, A. J., & Testa, J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.24.10854 · Cited by 360
Thoracoscopy--state of the art
Loddenkemper, R. (1998) · European Respiratory Journal · doi:10.1183/09031936.98.11010213 · Cited by 357
Asbestos Exposure, Pleural Mesothelioma, and Serum Osteopontin Levels
Pass, H. I., Lott, D., Lonardo, F., Harbut, M., Liu, Z., Tang, N., Carbone, M., Webb, C., & Wali, A. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051185 · Cited by 357
Diffuse Malignant Mesothelioma: Prospective Evaluation of 69 Patients
CHAHINIAN, A. P., PAJAK, T. F., HOLLAND, J. F., NORTON, L., AMBINDER, R. M., & MANDEL, E. M. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-6-746 · Cited by 354
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma
Allen, A. M., Czerminska, M., Jänne, P. A., Sugarbaker, D. J., Bueno, R., Harris, J. R., Court, L., & Baldini, E. H. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.012 · Cited by 351
Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma
Hodgson, D. C., Gilbert, E. S., Dores, G. M., Schonfeld, S. J., Lynch, C. F., Storm, H., Hall, P., Langmark, F., Pukkala, E., Andersson, M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.0936 · Cited by 351
Sterman, D. H., Treat, J., Litzky, L. A., Amin, K. M., Coonrod, L., Molnar-Kimber, K., Recio, A., Knox, L., Wilson, J. M., Albelda, S. M., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.7-1083 · Cited by 341
Mesothelin targeted cancer immunotherapy
Hassan, R., & Ho, M. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2007.08.028 · Cited by 340
Ohta, Y., Shridhar, V, Bright, R. K., Kalemkerian, G. P., Du, W., Carbone, M., Watanabe, Y., & Pass, H. I. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690650 · Cited by 335
Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study
Byrne, M. J., Davidson, J. A., Musk, A. W., Dewar, J., van Hazel, G., Buck, M., de Klerk, N. H., & Robinson, B. W. S. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.25 · Cited by 334
Husain, A. N., Colby, T. V., Ordóñez, N. G., Krausz, T., Borczuk, A., Cagle, P. T., Chirieac, L. R., Churg, A., Galateau-Salle, F., Gibbs, A. R., et al. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.8.1317 · Cited by 332
Weder, W., Stahel, R. A., Bernhard, J., Bodis, S., Vogt, P., Ballabeni, P., Lardinois, D., Betticher, D., Schmid, R., Stupp, R., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm093 · Cited by 320
p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.
Cheng, J. Q., Jhanwar, S., Klein, W. M., Bell, D. W., Lee, W.-C., Altomare, D. A., Nobori, T., Olopade, O. I., Buckler, A., & Testa, J. R. (1994) · PubMed · Cited by 319
Latency of asbestos disease among insulation workers in the United States and Canada
Selikoff, I. J., Hammond, E. C., & Seidman, H. (1980) · Cancer · doi:10.1002/1097-0142(19801215)46:12<2736::aid-cncr2820461233>3.0.co;2-l · Cited by 306
Patterns of Failure After Trimodality Therapy for Malignant Pleural Mesothelioma
Baldini, M., Recht, M., Strauss, M., DeCamp, M., Swanson, M., Liptay, M., Mentzer, M., & Sugarbaker, M. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(96)01228-3 · Cited by 302
Hassan, R., Remaley, A. T., Sampson, M. L., Zhang, J., Cox, D. D., Pingpank, J., Alexander, R., Willingham, M., Pastan, I., & Onda, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1477 · Cited by 296
Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)90162-0 · Cited by 296
Phase II Study of Pemetrexed Plus Carboplatin in Malignant Pleural Mesothelioma
Ceresoli, G. L., Zucali, P. A., Favaretto, A. G., Grossi, F., Bidoli, P., Del Conte, G., Ceribelli, A., Bearz, A., Morenghi, E., Cavina, R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3190 · Cited by 296
de Perrot, M., Feld, R., Cho, B. C. J., Bezjak, A., Anraku, M., Burkes, R., Roberts, H., Tsao, M. S., Leighl, N., Keshavjee, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5604 · Cited by 291
Malignant mesothelioma 1982: Review of 4710 published cases
Hillerdal, G. (1983) · British Journal of Diseases of the Chest · doi:10.1016/0007-0971(83)90068-2 · Cited by 289
Occupational exposure to asbestos: Population at risk and projected mortality‐1980–2030
Nicholson, W. J., Perkel, G., & Selikoff, I. J. (1982) · American Journal of Industrial Medicine · doi:10.1002/ajim.4700030305 · Cited by 289
The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050
Hodgson, J. T., McElvenny, D. M., Darnton, A. J., Price, M. J., & Peto, J. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602307 · Cited by 283
Analysis of Current Trends in United States Mesothelioma Incidence
Price, B. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009093 · Cited by 278
Mesothelioma Epidemiology, Carcinogenesis, and Pathogenesis
Yang, H., Testa, J. R., & Carbone, M. (2008) · Current Treatment Options in Oncology · doi:10.1007/s11864-008-0067-z · Cited by 274
Price, B. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh025 · Cited by 271
p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a
Krimpenfort, P., IJpenberg, A., Song, J.-Y., van der Valk, M., Nawijn, M., Zevenhoven, J., & Berns, A. (2007) · Nature · doi:10.1038/nature06084 · Cited by 269
Malignant Pleural Mesothelioma: Evaluation with CT, MR Imaging, and PET
Wang, Z. J., Reddy, G. P., Gotway, M. B., Higgins, C. B., Jablons, D. M., Ramaswamy, M., Hawkins, R. A., & Webb, W. R. (2004) · RadioGraphics · doi:10.1148/rg.241035058 · Cited by 267
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
Roushdy-Hammady, I., Siegel, J., Emri, S., Testa, J. R., & Carbone, M. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04013-7 · Cited by 266
Rusch, V. W., Piantadosi, S., & Holmes, E. C. (1991) · PubMed · Cited by 264
Muers, M. F., Stephens, R. J., Fisher, P., Darlison, L., Higgs, C. M., Lowry, E., Nicholson, A. G., O'Brien, M., Peake, M., Rudd, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60727-8 · Cited by 260
Bénard, F., Sterman, D., Smith, R. J., Kaiser, L. R., Albelda, S. M., & Alavi, A. (1998) · Chest · doi:10.1378/chest.114.3.713 · Cited by 260
Govindan, R., Kratzke, R. A., Herndon, J. E., Niehans, G. A., Vollmer, R., Watson, D., Green, M. R., Kindler, H. L., & on behalf of the Cancer and Leukemia Group B (CALGB 30101) (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1940 · Cited by 260
Self-citationAa, E., Saavedra, A., Zhang, H., Kucharczuk, J. C., Dc, S., Fishman, G. I., Km, A., Kaiser, L. R., & Albelda, S. (1996) · PubMed · Cited by 259
Kindler, H. L., Karrison, T. G., Gandara, D. R., Lu, C., Krug, L. M., Stevenson, J. P., Jänne, P. A., Quinn, D. I., Koczywas, M. N., Brahmer, J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5869 · Cited by 257
Self-citationOmenn, G. S., Goodman, G. E., Thornquist, M. D., Grizzle, J. E., Rosenstock, L., Barnhart, S., Balmes, J. R., Cherniack, M. G., Cullen, M. R., & Glass, A. G. (1994) · PubMed · Cited by 256
Santoro, A., O'Brien, M. E., Stahel, R. A., Nackaerts, K., Baas, P., Karthaus, M., Eberhardt, W., Paz-Ares, L., Sundstrom, S., Liu, Y., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31817c73d6 · Cited by 255
(1992) · PubMed · Cited by 252
Scagliotti, G. V., Shin, D.-M., Kindler, H. L., Vasconcelles, M. J., Keppler, U., Manegold, C., Burris, H., Gatzemeier, U., Blatter, J., Symanowski, J. T., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.122 · Cited by 251
Self-citationThe role of extrapleural pneumonectomy in malignant pleural mesothelioma
Rusch, V. W., Piantadosi, S., & Holmes, E. C. (1991) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)36577-8 · Cited by 250
Sugarbaker, D. J., Strauss, G. M., Lynch, T. J., Richards, W., Mentzer, S. J., Lee, T. H., Corson, J. M., & Antman, K. H. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1172 · Cited by 246
Steele, N. L., Plumb, J. A., Vidal, L., Tjørnelund, J., Knoblauch, P., Rasmussen, A., Ooi, C. E., Buhl-Jensen, P., Brown, R., Evans, T. R. J., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1786 · Cited by 244
Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma
Weder, W., Kestenholz, P., Taverna, C., Bodis, S., Lardinois, D., Jerman, M., & Stahel, R. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.071 · Cited by 241
Thoracoscopic Talc Poudrage Pleurodesis for Malignant Effusions
Viallat, J.-R., Rey, F., Astoul, P., & Boutin, C. (1996) · Chest · doi:10.1378/chest.110.6.1387 · Cited by 241
van de Vaart, P. J. M., van der Vange, N., Zoetmulder, F. A. N., van Goethem, A. R., van Tellingen, O., ten Bokkel Huinink, W. W., Beijnen, J. H., Bartelink, H., & Begg, A. C. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00370-5 · Cited by 238
Sugarbaker, D. J., Garcia, J. P., Richards, W. G., Harpole, D. H., Healy-Baldini, E., DeCamp, M. M., Mentzer, S. J., Liptay, M. J., Strauss, G. M., & Swanson, S. J. (1996) · Annals of Surgery · doi:10.1097/00000658-199609000-00005 · Cited by 237
Jassem, J., Ramlau, R., Santoro, A., Schuette, W., Chemaissani, A., Hong, S., Blatter, J., Adachi, S., Hanauske, A., & Manegold, C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.9887 · Cited by 231
Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers.
Alberts, A. S., Falkson, G., Goedhals, L., Vorobiof, D. A., & Van der Merwe, C. A. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.3.527 · Cited by 230
Hollevoet, K., Reitsma, J. B., Creaney, J., Grigoriu, B. D., Robinson, B. W., Scherpereel, A., Cristaudo, A., Pass, H. I., Nackaerts, K., Rodríguez Portal, J. A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.6671 · Cited by 230
Interdomain binding mediates tumor growth suppression by the NF2 gene product
Sherman, L., Xu, H.-M., Geist, R. T., Saporito-Irwin, S., Howells, N., Ponta, H., Herrlich, P., & Gutmann, D. H. (1997) · Oncogene · doi:10.1038/sj.onc.1201418 · Cited by 230
Flores, R. M., Zakowski, M., Venkatraman, E., Krug, L., Rosenzweig, K., Dycoco, J., Lee, C., Yeoh, C., Bains, M., & Rusch, V. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815608d9 · Cited by 229
Chemotherapy in malignant pleural mesothelioma. A review.
Ong, S. T., & Vogelzang, N. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.1007 · Cited by 225
Grigoriu, B.-D., Scherpereel, A., Devos, P., Chahine, B., Letourneux, M., Lebailly, P., Grégoire, M., Porte, H., Copin, M.-C., & Lassalle, P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2144 · Cited by 225
A multicentre phase II study of cisplatin and gemcitabine for malignant mesothelioma
Nowak, A. K., Byrne, M. J., Williamson, R., Ryan, G., Segal, A., Fielding, D., Mitchell, P., Musk, A. W., & Robinson, B. W. S. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600505 · Cited by 225
Richards, W. G., Zellos, L., Bueno, R., Jaklitsch, M. T., Jänne, P. A., Chirieac, L. R., Yeap, B. Y., Dekkers, R. J., Hartigan, P. M., Capalbo, L., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6813 · Cited by 223
Garland, L. L., Rankin, C., Gandara, D. R., Rivkin, S. E., Scott, K. M., Nagle, R. B., Klein-Szanto, A. J. P., Testa, J. R., Altomare, D. A., & Borden, E. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7634 · Cited by 221
Thoracoscopic Talc Insufflation Versus Talc Slurry for Symptomatic Malignant Pleural Effusion
Yim, A. P. C., Chan, A. T. C., Tak, W. L., Wan, I. Y. P., & Ho, J. K. S. (1996) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(96)00808-9 · Cited by 219
Flores, R. M., Akhurst, T., Gonen, M., Larson, S. M., & Rusch, V. W. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00207-1 · Cited by 217
Rice, D. C., Stevens, C. W., Correa, A. M., Vaporciyan, A. A., Tsao, A., Forster, K. M., Walsh, G. L., Swisher, S. G., Hofstetter, W. L., Mehran, R. J., et al. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.04.076 · Cited by 214
Self-citationDe Luca, A., Baldi, A., Esposito, V., Howard, C. M., Bagella, L., Rizzo, P., Caputi, M., Pass, H. I., Giordano, G. G., Baldi, F., et al. (1997) · Nature Medicine · doi:10.1038/nm0897-913 · Cited by 211
Lee, A. Y., He, B., You, L., Dadfarmay, S., Xu, Z., Mazieres, J., Mikami, I., McCormick, F., & Jablons, D. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207881 · Cited by 209
Price, B., & Ware, A. (2009) · Critical Reviews in Toxicology · doi:10.1080/10408440903044928 · Cited by 209
The importance of surgical staging in the treatment of malignant pleural mesothelioma
Rusch, V. W., & Venkatraman, E. (1996) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70342-2 · Cited by 205
Phase II Study of Vinorelbine in Patients With Malignant Pleural Mesothelioma
Steele, J. P. C., Shamash, J., Evans, M. T., Gower, N. H., Tischkowitz, M. D., & Rudd, R. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.23.3912 · Cited by 203
Melbye, M., Cook, P., Hjalgrim, H., Begtrup, K., Simpson, G. R., Biggar, R. J., Ebbesen, P., & Schulz, T. F. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980812)77:4<554::aid-ijc14>3.0.co;2-6 · Cited by 201
Molnar-Kimber, K. L., Sterman, D. H., Chang, M., Kang, E. H., ElBash, M., Lanuti, M., Elshami, A., Gelfand, K., Wilson, J. M., Kaiser, L. R., et al. (1998) · Human Gene Therapy · doi:10.1089/hum.1998.9.14-2121 · Cited by 200
Francis, R. J., Byrne, M. J., van der Schaaf, A. A., Boucek, J. A., Nowak, A. K., Phillips, M., Price, R., Patrikeos, A. P., Musk, A. W., & Millward, M. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042333 · Cited by 198
Functional Analysis of c-Met/Hepatocyte Growth Factor Pathway in Malignant Pleural Mesothelioma
Jagadeeswaran, R., Ma, P. C., Seiwert, T. Y., Jagadeeswaran, S., Zumba, O., Nallasura, V., Ahmed, S., Filiberti, R., Paganuzzi, M., Puntoni, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-4567 · Cited by 198
Self-citationMechanisms of Carcinogenesis and Clinical Features of Asbestos-Associated Cancers
Mossman, B. T., Kamp, D. W., & Weitzman, S. A. (1996) · Cancer Investigation · doi:10.3109/07357909609018904 · Cited by 197
Pass, H. I., Temeck, B. K., Kranda, K., Thomas, G., Russo, A., Smith, P., Friauf, W., & Steinberg, S. M. (1997) · Annals of Surgical Oncology · doi:10.1007/bf02303746 · Cited by 197
Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase
Jin, H., Sperka, T., Herrlich, P., & Morrison, H. (2006) · Nature · doi:10.1038/nature04856 · Cited by 193
Latency periods in asbestos-related mesothelioma of the pleura.
Bianchi, C., Giarelli, L., Grandi, G., Brollo, A., Ramani, L., & Zuch, C. (1997) · PubMed · Cited by 192
Contamination of Poliovirus Vaccines With Simian Virus 40 (1955-1963) and Subsequent Cancer Rates
Strickler, H. D. (1998) · JAMA · doi:10.1001/jama.279.4.292 · Cited by 192
Berghmans, T., Paesmans, M., Lalami, Y., Louviaux, I., Luce, S., Mascaux, C., Meert, A. P., & Sculier, J. P. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00180-0 · Cited by 190
Ordóǹez, N. G. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199810000-00006 · Cited by 190
Preclinical evaluation of MORAb-009, a chimeric antibody targeting tumor-associated mesothelin.
Hassan, R., Ebel, W., Routhier, E., Patel, R. K., Kline, J. B., Zhang, J., Chao, Q., Jacob, S. M., Turchin, H. A., Gibbs, L. S., et al. (2007) · PubMed · Cited by 186
Szlosarek, P. W., Klabatsa, A., Pallaska, A., Sheaff, M., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P., Rudd, R. M., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181
A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma
O’Rourke, N., Garcia, J. C., Paul, J., Lawless, C., McMenemin, R., & Hill, J. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2007.05.022 · Cited by 180
Bydder, S., Phillips, M., Joseph, D. J., Cameron, F., Spry, N. A., DeMelker, Y., & Musk, A. W. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601957 · Cited by 179
Rusch, V. W. (1996) · Lung Cancer · doi:10.1016/0169-5002(95)00508-0 · Cited by 179
Poulikakos, P. I., Xiao, G.-H., Gallagher, R., Jablonski, S., Jhanwar, S. C., & Testa, J. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209587 · Cited by 178
Testa, J. R., Carbone, M., Hirvonen, A., Khalili, K., Krynska, B., Linnainmaa, K., Pooley, F. D., Rizzo, P., Rusch, V. W., & Xiao, G. H. (1998) · PubMed · Cited by 176
Tilleman, T. R., Richards, W. G., Zellos, L., Johnson, B. E., Jaklitsch, M. T., Mueller, J., Yeap, B. Y., Mujoomdar, A. A., Ducko, C. T., Bueno, R., et al. (2009) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2009.02.046 · Cited by 173
Genetic Predisposition to Fiber Carcinogenesis Causes a Mesothelioma Epidemic in Turkey
Dogan, A. U., Baris, Y. I., Dogan, M., Emri, S., Steele, I., Elmishad, A. G., & Carbone, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4642 · Cited by 172
Erasmus, J. J., Truong, M. T., Smythe, W. R., Munden, R. F., Marom, E. M., Rice, D. C., Vaporciyan, A. A., Walsh, G. L., Sabloff, B. S., Broemeling, L. D., et al. (2005) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.10.034 · Cited by 171
Ordóñez, N. G. (2007) · Human Pathology · doi:10.1016/j.humpath.2006.08.010 · Cited by 170
Flores, R. M., Krug, L. M., Rosenzweig, K. E., Venkatraman, E., Vincent, A., Heelan, R., Akhurst, T., & Rusch, V. W. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)31583-5 · Cited by 167
Clinical Significance of Serum Mesothelin in Patients with Mesothelioma and Lung Cancer
Cristaudo, A., Foddis, R., Vivaldi, A., Guglielmi, G., Dipalma, N., Filiberti, R., Neri, M., Ceppi, M., Paganuzzi, M., Ivaldi, G. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0629 · Cited by 164
Iwatsubo, Y., Pairon, J. C., Boutin, C., Menard, O., Massin, N., Caillaud, D., Orlowski, E., Galateau-Salle, F., Bignon, J., & Brochard, P. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009616 · Cited by 161
Ceresoli, G. L., Chiti, A., Zucali, P. A., Rodari, M., Lutman, R. F., Salamina, S., Incarbone, M., Alloisio, M., & Santoro, A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.8999 · Cited by 161
Rice, D. C., Smythe, W. R., Liao, Z. X., Guerrero, T. M., Chang, J. Y., McAleer, M. F., Jeter, M. D., Correa, A. M., Vaporciyan, A. A., Liu, H. H., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.03.011 · Cited by 161
Boutin, C., Nussbaum, E., Monnet, I., Bignon, J., Vanderschueren, R. G. J. R. A., Guérin, J., Ménard, O., Mignot, P., Dabouis, G., & Douillard, J.-Y. (1994) · Cancer · Cited by 160
Sterman, D. H., Recio, A., Carroll, R. G., Gillespie, C. T., Haas, A. R., Vachani, A., Kapoor, V., Sun, J., Hodinka, R. L., Brown, J. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0403 · Cited by 160
Manegold, C., Symanowski, J., Gatzemeier, U., Reck, M., von Pawel, J., Kortsik, C., Nackaerts, K., Lianes, P., & Vogelzang, N. J. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi187 · Cited by 160
Multicentre phase II study of gemcitabine and cisplatin in malignant pleural mesothelioma
van Haarst, J. M. W., Baas, P., Manegold, C., Schouwink, J. H., Burgers, J. A., de Bruin, H. G., Mooi, W. J., van Klaveren, R. J., de Jonge, M. J. A., & van Meerbeeck, J. P. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600118 · Cited by 159
Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma
Gupta, V., Mychalczak, B., Krug, L., Flores, R., Bains, M., Rusch, V. W., & Rosenzweig, K. E. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.041 · Cited by 159
Altomare, D. A., You, H., Xiao, G.-H., Ramos-Nino, M. E., Skele, K. L., De Rienzo, A., Jhanwar, S. C., Mossman, B. T., Kane, A. B., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208744 · Cited by 158
Marinaccio, A., Binazzi, A., Cauzillo, G., Cavone, D., Zotti, R. D., Ferrante, P., Gennaro, V., Gorini, G., Menegozzo, M., Mensi, C., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.09.018 · Cited by 158
Radiation sensitivity of human lung cancer cell lines
Carmichael, J., DeGraff, W., Gamson, J., Russo, D., Gazdar, A. F., Levitt, M. L., Minna, J. D., & Mitchell, J. B. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90266-6 · Cited by 157
The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma
Stebbing, J., Powles, T. B., McPherson, K., Shamash, J., Wells, P., Sheaff, M. T., Slater, S., Rudd, R., Fennell, D. A., & Steele, J. P. C. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.04.001 · Cited by 155
Thödtmann, R., Depenbrock, H., Dumez, H., Blatter, J., Johnson, R. D., van Oosterom, A., & Hanauske, A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.10.3009 · Cited by 151
Changing trends in US mesothelioma incidence
Weill, H., Hughes, J., & Churg, A. (2004) · Occupational and Environmental Medicine · doi:10.1136/oem.2003.010165 · Cited by 150
Jacquet, P., Averbach, A. M., Stuart, O. A., Chang, D. W.-W., & Sugarbaker, P. H. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050721 · Cited by 148
Ahamad, A. W., Stevens, C. W., Smythe, W. R., Vaporciyan, A. A., Komaki, R. U., Kelly, J. F., Liao, Z. X., Starkschall, G., & Forster, K. M. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04151-2 · Cited by 147
Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma
Yajnik, S. V., Rosenzweig, K. E., Mychalczak, B. R., Krug, L. M., Flores, R. M., Hong, L. X., & Rusch, V. W. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(03)00287-6 · Cited by 145
Malignant Pleural Mesothelioma
Ray, M., & Kindler, H. L. (2009) · CHEST Journal · doi:10.1378/chest.08-2665 · Cited by 145
Self-citationRea, F., Marulli, G., Bortolotti, L., Breda, C., Favaretto, A. G., Loreggian, L., & Sartori, F. (2007) · Lung Cancer · doi:10.1016/j.lungcan.2007.02.004 · Cited by 144
Sterman, D. H., Recio, A., Vachani, A., Sun, J., Cheung, L., DeLong, P. A., Amin, K. M., Litzky, L. A., Wilson, J. M., Kaiser, L. R., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0405 · Cited by 144
Malignant mesothelioma in Australia, 1945–2000*
Leigh, J., Davidson, P., Hendrie, L., & Berry, D. (2002) · American Journal of Industrial Medicine · doi:10.1002/ajim.10047 · Cited by 142
Castagneto, B., Botta, M., Aitini, E., Spigno, F., Degiovanni, D., Alabiso, O., Serra, M., Muzio, A., Carbone, R. G., Buosi, R., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm501 · Cited by 141
Bölükbas, S., Manegold, C., Eberlein, M. H., Bergmann, T. J., Fisseler‐Eckhoff, A., & Schirren, J. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.08.019 · Cited by 140
Cacciotti, P., Libener, R., Betta, P., Martini, F., Porta, C., Procopio, A. D., Strizzi, L., Penengo, L., Tognon, M. G., Mutti, L., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211026798 · Cited by 140
High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study
Solheim, Ø. P., Sæter, G., Finnanger, A., & Stenwig, A. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.200 · Cited by 139
A Conditional Mouse Model for Malignant Mesothelioma
Jongsma, J., van Montfort, E. H. N., Vooijs, M., Zevenhoven, J., Krimpenfort, P., van der Valk, M., van de Vijver, M. J., & Berns, A. J. M. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.030 · Cited by 138
Adenovirus-Mediated p14ARF Gene Transfer in Human Mesothelioma Cells
Yang, C., You, L., Yeh, C., Chang, J. W. C., Zhang, F., McCormick, F. P., & Jablons, D. M. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.8.636 · Cited by 138
Advances in the systemic therapy of malignant pleural mesothelioma
Fennell, D. A., Gaudino, G., O'Byrne, K. J., Mutti, L., & van Meerbeeck, J. P. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1039 · Cited by 136
Fluorodeoxyglucose Positron Emission Tomography and CT After Talc Pleurodesis
Kwek, B. H., Aquino, S. L., & Fischman, A. J. (2004) · CHEST Journal · doi:10.1378/chest.125.6.2356 · Cited by 135
Nonoccupational Exposure to Chrysotile Asbestos and the Risk of Lung Cancer
Camus, M., Siemiatycki, J., & Meek, B. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805283382201 · Cited by 135
Schmitter, D., Lauber, B., Fagg, B., & Stahel, R. A. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910510220 · Cited by 133
Fizazi, K. S., Doubre, H., Chevalier, T. L., Riviere, A., Viala, J., Daniel, C., Robert, L., Barthélemy, P., Fandi, A., & Ruffiè, P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.123 · Cited by 132
Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma.
Toyooka, S., Pass, H. I., Shivapurkar, N., Fukuyama, Y., Maruyama, R., Toyooka, K. O., Gilcrease, M. Z., Farinas, A. J., Minna, J. D., & Gazdar, A. F. (2001) · PubMed · Cited by 131
Chahinian, A. P. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)90394-8 · Cited by 128
Limited efficacy of imatinib mesylate in malignant mesothelioma: A phase II trial
Mathy, A., Baas, P., Dalesio, O., & van Zandwijk, N. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.04.010 · Cited by 127
Arginine deiminase, a potential anti-tumor drug
Ni, Y., Schwaneberg, U., & Sun, Z. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.038 · Cited by 127
Janne, P. A., von Pawel, J., Cohen, R. B., Crinò, L., Butts, C. A., Olson, S. S., Eiseman, I. A., Chiappori, A., Yeap, B. Y., Lenehan, P. F., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.1336 · Cited by 126
Frizelle, S. P., Grim, J. E., Zhou, J. X., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201870 · Cited by 126
van Klaveren, R. V., Aerts, J., de Bruin, H. D., Giaccone, G., Manegold, C., & van Meerbeeck, J. V. (2004) · Lung Cancer · doi:10.1016/s0169-5002(03)00292-7 · Cited by 126
Ionizing radiation: a risk factor for mesothelioma
Goodman, J. E., Nascarella, M. A., & Valberg, P. A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9357-4 · Cited by 125
Well-differentiated Papillary Mesothelioma of the Pleura: A Series of 24 Cases
Galateau-Sallé, F., Vignaud, J.-M., Burke, L. M., Gibbs, A. R., Brambilla, E. M., Attanoos, R. L., Goldberg, M., & Launoy, G. D. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00013 · Cited by 125
Ceresoli, G. L., Locati, L. D., Ferreri, A. J. M., et al. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00257-4 · Cited by 123
Cao, X. X., Mohuiddin, I., Ece, F., McConkey, D. J., & Smythe, W. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.25.5.4539 · Cited by 123
O'Brien, M. E. R., Watkins, D. J., Ryan, C., Priest, K., Corbishley, C. M., Norton, A., Ashley, S., Rowell, N. P., & Sayer, R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdj073 · Cited by 123
Kratzke, R. A., Otterson, G. A., Lincoln, C. E., Ewing, S. L., Oie, H. K., Geradts, J., & Kaye, F. J. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.24.1870 · Cited by 122
Nakano, T., Chahinian, A. P., Shinjyo, M., Tonomura, A., Miyake, M., Togawa, N., Ninomiya, K., & Higashino, K. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.150 · Cited by 122
Reactive Mesothelial Hyperplasia vs Mesothelioma, Including Mesothelioma In Situ: A Brief Review
Henderson, D. W., SHILKIN, K. B., & Whitaker, D. (1998) · American Journal of Clinical Pathology · doi:10.1093/ajcp/110.3.397 · Cited by 121
de Graaf-Strukowska, L., van der Zee, J., van Putten, W., & Senan, S. (1999) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(98)00409-x · Cited by 121
Creaney, J., Yeoman, D., Demelker, Y., Segal, A., Musk, A. W., Skates, S. J., & Robinson, B. W. S. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318180477b · Cited by 121
Tsao, A. S., He, D., Saigal, B., Liu, S., Lee, J. J., Bakkannagari, S., Ordóǹez, N. G., Hong, W. K., Wistuba, I. I., & Johnson, F. M. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0052 · Cited by 121
Self-citationKrug, L. M., Curley, T., Schwartz, L. B., Richardson, S., Marks, P. A., Chiao, J. H., & Kelly, W. K. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.003 · Cited by 120
Ceresoli, G. L., Castagneto, B., Zucali, P. A., Favaretto, A. G., Mencoboni, M., Grossi, F., Cortinovis, D. L., Conte, G. D., Ceribelli, A., Bearz, A., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604442 · Cited by 119
Shedding light on Merlin's wizardry
Okada, T., You, L., & Giancotti, F. G. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.03.006 · Cited by 117
Favaretto, A. G., Aversa, S. M. L., Paccagnella, A., Manzini, V. D. P., Palmisano, V., Oniga, F., Stefani, M., Rea, F., Bortolotti, L., Loreggian, L., et al. (2003) · Cancer · doi:10.1002/cncr.11405 · Cited by 113
Ellis, P., Davies, A. M., Evans, W. K., Haynes, A. E., & Lloyd, N. S. (2006) · Journal of Thoracic Oncology · doi:10.1016/s1556-0864(15)30366-x · Cited by 113
The Mesothelioma epidemic in Western Europe: an update
Pelucchi, C., Malvezzi, M., Vecchia, C. L., Levi, F., Decarli, A., & Negri, E. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601638 · Cited by 112
Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up
Moskal, T. L., Dougherty, T. J., Urschel, J. D., Antkowiak, J. G., Régal, A.-M., Driscoll, D. L., & Takita, H. (1998) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(98)00799-1 · Cited by 112
Björkqvist, A.-M., Tammilehto, L., Nordling, S., Nurminen, M., Anttila, S. L., Mattson, K. V., & Knuutila, S. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.42 · Cited by 110
Malignant Pleural Mesothelioma: Surgical Management in 285 Patients
Schipper, P. H., Nichols, F. C., Thomse, K. M., Deschamps, C. C., Cassivi, S. D., Allen, M. S., & Pairolero, P. C. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2007.06.066 · Cited by 110
Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
Jackman, D. M., Kindler, H. L., Yeap, B. Y., Fidias, P. M., Salgia, R., Lucca, J. V., Morse, L. K., Ostler, P. A., Johnson, B. E., & Janne, P. A. (2008) · Cancer · doi:10.1002/cncr.23617 · Cited by 110
Self-citationSmythe, W. R., Hwang, H. C., Elshami, A. A., Amin, K. M., Eck, S. L., Davidson, B. L., Wilson, J. M., Kaiser, L. R., & Albeida, S. M. (1995) · Annals of Surgery · doi:10.1097/00000658-199507000-00013 · Cited by 109
Fennell, D. A., Parmar, A., Shamash, J., Evans, M. T., Sheaff, M. T., Sylvester, R. J., Dhaliwal, K., Gower, N. H., Steele, J. P. C., & Rudd, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.050 · Cited by 109
Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study
Goey, S. H., Eggermont, A. M. M., Punt, C. J. A., Slingerland, R., Gratama, J., Oosterom, R., Oskam, R., Bolhuis, R., & Stoter, G. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.501 · Cited by 108
Post-irradiation malignant mesothelioma
Cavazza, A., Travis, L. B., Travis, W. D., Wolfe, J. T., Foo, M. L., Gillespie, D. J., Weidner, N., & Colby, T. V. (1996) · Cancer · Cited by 108
Soluble mesothelin-related protein—A blood test for mesothelioma
Robinson, B. W. S., Creaney, J., Lake, R., Nowak, A. K., Musk, A. W., de Klerk, N. H., Winzell, P., Hellström, K. E., & Hellström, I. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.03.020 · Cited by 107
Application of immunohistochemistry to the diagnosis of malignant mesothelioma.
Marchevsky, A. M. (2008) · PubMed · doi:10.5858/2008-132-397-aoittd · Cited by 107
Nishikawa, K., Takahashi, K., Karjalainen, A., Wen, C.-P., Furuya, S., Hoshuyama, T., Todoroki, M., Kiyomoto, Y., Wilson, D., Higashi, T., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11272 · Cited by 106
Histone Deacetylase Inhibitors for Cancer Therapy
Kim, T., Bang, Y., & Robertson, K. D. (2006) · Epigenetics · doi:10.4161/epi.1.1.2644 · Cited by 106
Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807)
Otterson, G. A., Herndon, J. E., Watson, D. M., Green, M. R., & Kindler, H. L. (2003) · Lung Cancer · doi:10.1016/j.lungcan.2003.10.011 · Cited by 106
Self-citationUpdate on the molecular biology of malignant mesothelioma
Lee, A. Y., Raz, D. J., He, B., & Jablons, D. M. (2007) · Cancer · doi:10.1002/cncr.22552 · Cited by 105
Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma
Wheatley‐Price, P., Yang, B., Patsios, D., Patel, D., Ma, C., Xu, W., Leighl, N. B., Feld, R. D., Cho, B. C. J., O'Sullivan, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.9944 · Cited by 105
Intensity-Modulated Radiotherapy for Resected Mesothelioma: The Duke Experience
Miles, E. F., Larrier, N., Kelsey, C. R., Hubbs, J. L., Ma, J., Yoo, S., & Marks, L. B. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.11.011 · Cited by 105
Pleural mesothelioma: little evidence, still time to do trials
Treasure, T., & Sedrakyan, A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17108-0 · Cited by 103
Gemcitabine and vinorelbine in pemetrexed‐pretreated patients with malignant pleural mesothelioma
Zucali, P. A., Ceresoli, G. L., Garassino, I. M. G., Vincenzo, F. D., Cavina, R., Campagnoli, E., Cappuzzo, F., Salamina, S., Parra, H. J. S., & Santoro, A. (2008) · Cancer · doi:10.1002/cncr.23337 · Cited by 100
Fleury‐Feith, J., Boulangé-Lecomte, C., Renier, A., Matrat, M., Kheuang, L., Abramowski, V., Levy, F., Janin, A., Giovannini, M., & Jaurand, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206593 · Cited by 100
Intrapleural Recombinant IL-2 in Passive Immunotherapy for Malignant Pleural Effusion
Astoul, P. J., Viallat, J. R., Laurent, J. C., Brandely, M., & Boutin, C. (1993) · CHEST Journal · doi:10.1378/chest.103.1.209 · Cited by 99
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers
Arakawa, H., Hayashl, N., Nagase, H., Ogawa, M., & Nakamura, Y. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.4.565 · Cited by 99
Schulze, M., Boehle, A. S., Kurdow, R., Dohrmann, P., & Henne‐Bruns, D. (2001) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(01)02586-3 · Cited by 98
Stahel, R. A., Weder, W., Lievens, Y. N., & Felip, E. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq173 · Cited by 98
Liu, F., Zhao, B., Krug, L. M., Ishill, N. M., Lim, R., Guo, P., Gorski, M., Flores, R. M., Moskowitz, C. S., Rusch, V. W., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181dd0ef1 · Cited by 97
Humanized Anti-CD26 Monoclonal Antibody as a Treatment for Malignant Mesothelioma Tumors
Inamoto, T., Yamada, T., Ohnuma, K., Kina, S., Takahashi, N., Yamochi, T., Inamoto, S., Katsuoka, Y., Hosono, O., Tanaka, H., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0110 · Cited by 97
Hwang, H. C., Smythe, W. R., Elshami, A. A., Kucharczuk, J. C., Amin, K. M., Williams, J. P., Litzky, L. A., Kaiser, L. R., & Albelda, S. Μ. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.1.7598939 · Cited by 96
Pepper, C. J., Jasani, B., Navabi, H., Wynford‐Thomas, D., & Gibbs, A. R. (1996) · Thorax · doi:10.1136/thx.51.11.1074 · Cited by 96
Diagnostic Performance of Soluble Mesothelin and Megakaryocyte Potentiating Factor in Mesothelioma
Hollevoet, K., Nackaerts, K., Thimpont, J., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200907-1020oc · Cited by 95
Cited by
RECIST revisited: A review of validation studies on tumour assessment
Therasse, P., Eisenhauer, E. A., & Verweij, J. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.026 · Cited by 422
Kao, S. C. H., Pavlakis, N., Harvie, R., Vardy, J. L., Boyer, M. J., van Zandwijk, N., & Clarke, S. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2245 · Cited by 316
Measures of Response: RECIST, WHO, and New Alternatives
Jaffe, C. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.5599 · Cited by 302
Molecular pathogenesis of malignant mesothelioma
Sekido, Y. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt166 · Cited by 279
Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma
Reid, G., Pel, M. E., Kirschner, M. B., Cheng, Y. Y., Mugridge, N., Weiss, J., Williams, M., Wright, C., Edelman, J. J. B., Vallely, M. P., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt412 · Cited by 275
Metadata
- Authors
- Tsao, A. S., Wistuba, I., Roth, J. A., & Kindler, H. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2009-04-20
- Volume
- 27
- Issue
- 12
- Pages
- 2081-2090
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2095824051
- Cited by
- 481
- References
- 344
- FWCI
- 31.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.